Owlet (OWLT) Cash from Financing Activities (2020 - 2026)
Owlet's (OWLT) quarterly Cash from Financing Activities came in at $5.5 million in Q1 2026, up 171.2% year-on-year from $2.0 million in Q1 2025, and down 69.47% on a QoQ basis from $17.9 million in Q4 2025.
Owlet (OWLT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Cash from Financing Activities data on file, last reported at $5.5 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 171.2% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $35.6 million, a 177.29% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 100.17% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $5.5 million, down from $17.9 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for OWLT reached as high as $22.9 million in Q1 2023 and fell as low as -$4.4 million in Q3 2023.
- Historically, Cash from Financing Activities has averaged $4.8 million across 5 years, with a median of $3.0 million in 2023.
- Across the five-year window, Cash from Financing Activities sank 321.79% in 2023 and surged 2033.42% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at -$2.0 million in 2022, then surged by 253.22% to $3.0 million in 2023, then plunged by 236.24% to -$4.1 million in 2024, then soared by 538.21% to $17.9 million in 2025, then sank by 69.47% to $5.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $5.5 million in Q1 2026, $17.9 million in Q4 2025, and $4.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | -25.00 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | -26.93 Mn |
| 10 | Owlet | 148.59 Mn | 107.59 Mn | 12.24 Mn | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Jun 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Mar 31, 2024 | 5.23 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |